NELARABINE

NDC 72205-154 · Novadoz Pharmaceuticals LLC

Generic nameNELARABINE

Dosage formINJECTION

RouteINTRAVENOUS

Active ingredient(s)NELARABINE

Strength5 mg/mL

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

72205-154-01 — 1 VIAL in 1 CARTON (72205-154-01) / 50 mL in 1 VIAL

72205-154-04 — 6 VIAL in 1 CARTON (72205-154-04) / 50 mL in 1 VIAL

Billed under HCPCS

J9261 — Injection, nelarabine, 50 mg Medicare Part B payment limit (ASP + 6%): $40.87

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0078-0683 — nelarabine, 25021-259 — Nelarabine, 39822-0650 — Nelarabine, 43598-142 — Nelarabine, 46708-813 — nelarabine, 62332-813 — nelarabine, 66758-165 — nelarabine, 68083-233 — Nelarabine, 70121-1743 — Nelarabine, 70710-1726 — Nelarabine, 70710-1839 — Nelarabine, 70771-1685 — Nelarabine, 71288-165 — Nelarabine, 81927-111 — nelarabine, 81927-375 — nelarabine

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources